Navigation Links
Dyadic International Reports Q2 2014 Financial Results
Date:8/14/2014

prnews_span">19,755- Cost of Patents (45,373)(34,924) Restricted Cash29,0493,024 Net Cash (Used In) Investing Activities (163,785)(131,977) Financing Activities  Proceeds from Stock Warrant Exercises -64,803 Proceeds from Stock Option Exercises -58,500 Proceeds from Repayment of Stock Subscriptions Receivable 40,000- Net Cash Provided by Financing Activities 40,000123,303 Net Increase (Decrease) in Cash and Cash Equivalents (4,591,902)3,058,094 Cash and Cash Equivalents at Beginning of Period 8,892,3963,990,062 Cash and Cash Equivalents at End of Period 

$

4,300,494$

7,048,156 Supplemental Cash Flow Information:  Cash Paid for Interest 

$

340,687$

169,745 Non-Cash Item:  Conversion of Convertible Debt into Shares of Common Stock 

$

-$

182,00
'/>"/>

SOURCE Dyadic International, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Dyadic And CIMV Enter Into Collaboration To Commercialize Second Generation Biofuel Technology
2. Thomas Dubinski joins Dyadic as Chief Financial Officer
3. Dyadic International To Present At Two Major Conferences In December 2013
4. Dyadic International Reports Third Quarter 2013 Financial Results
5. Dyadic International To Announce Third Quarter 2013 Financial Results And Host Conference Call On Thursday, November 14, 2013
6. Dyadic International Reports Second Quarter 2013 Financial Results
7. Dyadic International To Present At World Biotechnology Congress 2013 And BIO World Congress On Industrial Biotech
8. Dyadic International Reports First Quarter 2013 Financial Results
9. Dyadic International To Announce First Quarter 2013 Financial Results And Host Conference Call On Wednesday, May 15, 2013
10. Danai Brooks Joins Dyadic International as Chief Operating Officer
11. Dyadic International To Speak At Advanced Biofuels Leadership Conference Panel Discussion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... -- Bionomics Limited (ASX:BNO, ADR:BMICY) is to present important ... patients with metastatic renal cancer at the ASCO Genitourinary ... The data will be presented by Dr. Sumanta ... Center in California in his ... Ferritin and IL-8 as two baseline biomarkers that correlate ...
(Date:2/27/2015)... BOSTON , Feb. 27, 2015   PureTech ... identifying, inventing and commercializing disruptive products and technologies in ... Christopher Viehbacher , former CEO and Member of the ... Directors.  "It,s has been a pleasure ... very excited that we will be working together more ...
(Date:2/26/2015)... 2015   Synageva BioPharma Corp. (NASDAQ: ... therapeutic products for rare disorders, today reported 2014 ... other key objectives, and financial guidance.  Synageva,s management ... 4:30 p.m. EST to review the financial results ... in today,s call by telephone, please dial (877) ...
(Date:2/26/2015)... On behalf of biotech client GenScript ... Goldman & Spitzer, P.A. (Wilentz) secured a significant ... Inc. in excess of $10 million. The jury determined ... and that it improperly hired one or more of ... motions for judgment notwithstanding the verdict, a new trial, ...
Breaking Biology Technology:New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3
... kb targets from eukaryotic genomes Cat. No. , 1 681 834 100 units , ... 250 units , Cat. No. 1 759 060 10 x 250 units , ... , , Unique enzyme blend of Taq and Pwo DNA Polymerase. The ... , , PCR buffer ...
... , , , , , , ... for nucleic acid amplification. For detailed information about a product , please ... Protector , RNase Inhibitor , , ... , is a new type of RNase ...
... , , , , , ... Primer anneal. temp. , Sensitivity , Specifi- , ... Tolerance , of non- , ... of serum components , Carry-over , ...
Cached Biology Technology:Expand Long Template PCR System 2Product overview 2Product overview 3Product overview 4Product overview 5Product overview 6Product overview 7Reverse transcriptases suitable for one-step RT-PCRb 2
(Date:1/22/2015)... Technology Showcase, Hall E -   EyeLock Inc. , a ... will showcase its EyeLock ID technology integrated in a 3D ... Oak Ridge National Laboratory (ORNL) at the 2015 ... authentication technology is being used to validate the driver and ...
(Date:1/22/2015)... , Jan. 16, 2015  A man-made form of insulin ... other mental capabilities in adults with mild cognitive impairment ... led by researchers at Wake Forest Baptist Medical Center. ... with amnesic mild cognitive impairment (MCI) or mild to ...
(Date:1/22/2015)... YORK and POINT ROBERTS, Washington ... news source covering leading sectors including technology and tech stocks, ... Privacy marketplace featuring master pickpocket and security consultant Apollo ... is stolen and talks about the Wocket™ biometric smart wallet, ...
Breaking Biology News(10 mins):EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3
... Scientists in Canada have overcome a key research ... disease with a technique to produce medically useful amounts ... research, published in Biotechnology and Bioengineering , can ... helping scientists to navigate the route to clinical use ...
... release is available in German . , ... a dormant state with a significantly reduced metabolism and are ... The water content of maturing seeds is lower than ten ... Research in Cologne have now discovered that the genetic material ...
... damaged, dormant adult stem cells called satellite cells are ... muscle. University of Missouri researchers recently found how even ... are now learning how the stem cells travel within ... effectively treat muscle disorders such as muscular dystrophy, in ...
Cached Biology News:Scalable amounts of liver and pancreas precursor cells created using new stem cell production method 2Plant seeds protect their genetic material against dehydration 2Adult stem cells use special pathways to repair damaged muscle, MU researchers find 2
activating transcription factor 4 (tax-responsive enhancer element B67),...
The Hybrid Hunter Yeast Two-Hybrid System uses the activation of reporter genes to indicate positive protein-protein interactions. Two reporters are used an auxotrophic marker and lacZ....
Request Info...
Sprague Dawley rats, 7-8 weeks of age, mixed gender; collected by exsanguination in Alsever's solution at 1:2 dilution...
Biology Products: